在恶性贫血中服用口服维生素B12补充剂:一项前性队列研究
Valentin Lacombe1, Emeline Vinatier2, Guillaume Roquin3
1Department of Internal Medicine and Clinical Immunology, University Hospital, Angers, France; MitoVasc unit, Inserm U1083, CNRS UMR6015, Angers University, France.
口服维生素B12补充剂通过纠正维生素B12缺乏症,有效治疗恶性贫血 (PA). 这项研究表明,每天口服的亚诺科巴胺是PA患者注射的一种可行的替代方案.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 血液学 血液学 血液学
背景情况:
- 恶性贫血 (PA) 损害了维生素B12的吸收,原因是内在因子缺乏.
- 肌肉内注射维生素B12是传统的治疗方法,绕过吸收不良.
- 口服维生素B12补充剂在PA中的有效性仍未得到充分研究.
研究的目的:
- 在患有恶性贫血的患者中评估口服维生素B12补充剂的有效性.
主要方法:
- 纳入了26名与PA相关的维生素B12缺乏症患者.
- 通过免疫性胃炎和特定抗体证实了诊断.
- 通过血B12,同类半氨酸,pMMA和尿液MMA/肌氨酸评估维生素B12状态.
- 在12个月内接受1000微克/天口服蓝胺的治疗.
主要成果:
- 88.5%的患者在1个月后达到正常的维生素B12水平.
- 在血B12,同型半氨酸和pMMA水平上观察到显著的改善.
- 在12个月的随访期间,生物化学改善一直持续.
- 逆转缺乏异常的中位时间从1到4个月不等.
结论:
- 每天口服的蓝素 (1000微克/天) 有效地纠正了PA中的维生素B12缺乏.
- 口服补充剂为PA患者提供了一个有前途的替代治疗方法.
更多相关视频
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
05:03Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
相关概念视频
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Vitamins
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability Study Design: Healthy Subjects Versus Patients
